TreeWAS – Variant ID: rs9295924

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E03.9 Hypothyroidism, unspecified	0.000	0.000	1.000
K90.0 Coeliac disease	0.000	0.000	1.000
L40.9 Psoriasis, unspecified	1.000	0.000	0.000
L40.5 Arthropathic psoriasis	1.000	0.000	0.000
L40 Psoriasis	1.000	0.000	0.000
E00-E07 Disorders of thyroid gland	0.000	0.000	1.000
E10 Insulin-dependent diabetes mellitus	0.000	0.000	1.000
E10.9 Without complications	0.000	0.000	1.000
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.000	1.000
E03 Other hypothyroidism	0.000	0.000	1.000
E05.9 Thyrotoxicosis, unspecified	0.000	0.001	0.999
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.003	0.997
E10-E14 Diabetes mellitus	0.000	0.003	0.997
T36-T50 Poisoning by drugs, medicaments and biological substances	0.993	0.007	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.008	0.992
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.991	0.009	0.000
L40.0 Psoriasis vulgaris	0.984	0.016	0.000
E50-E64 Other nutritional deficiencies	0.000	0.017	0.983
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.976	0.024	0.000
E53 Deficiency of other B group vitamins	0.000	0.030	0.970
T43.2 Other and unspecified antidepressants	0.966	0.034	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.964	0.036	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.961	0.039	0.000
E53.8 Deficiency of other specified B group vitamins	0.000	0.040	0.960
E10.3 With ophthalmic complications	0.000	0.045	0.955
E10.4 With neurological complications	0.000	0.054	0.946
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.938	0.062	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.932	0.068	0.000
E10.5 With peripheral circulatory complications	0.000	0.072	0.928
T50.9 Other and unspecified drugs, medicaments and biological substances	0.926	0.074	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.903	0.097	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.903	0.097	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.901	0.099	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.887	0.113	0.000
L40.1 Generalised pustular psoriasis	0.886	0.114	0.000
T39.1 4-Aminophenol derivatives	0.873	0.127	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.863	0.137	0.000
E06 Thyroiditis	0.000	0.150	0.850
E10.2 With renal complications	0.000	0.163	0.837
T42.4 Benzodiazepines	0.830	0.170	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.814	0.186	0.000
T43.6 Psychostimulants with abuse potential	0.806	0.194	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.201	0.799
E55 Vitamin D deficiency	0.000	0.211	0.789
T50.6 Antidotes and chelating agents, not elsewhere classified	0.786	0.214	0.000
E04 Other non-toxic goitre	0.000	0.222	0.778
E10.8 With unspecified complications	0.000	0.224	0.776
E05.8 Other thyrotoxicosis	0.000	0.226	0.773
L40.8 Other psoriasis	0.773	0.227	0.000
E06.3 Autoimmune thyroiditis	0.000	0.238	0.762
E10.6 With other specified complications	0.000	0.245	0.755
E10.0 With coma	0.000	0.247	0.753
T46 Poisoning by agents primarily affecting the cardiovascular system	0.750	0.250	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.749	0.251	0.000
E04.9 Non-toxic goitre, unspecified	0.000	0.257	0.743
T39.0 Salicylates	0.734	0.266	0.000
T47.0 Histamine H(2)-receptor antagonists	0.718	0.282	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.717	0.283	0.000
L40.4 Guttate psoriasis	0.717	0.283	0.000
L40.3 Pustulosis palmaris et plantaris	0.717	0.283	0.000
L40.2 Acrodermatitis continua	0.717	0.283	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.283	0.717
E00 Congenital iodine-deficiency syndrome	0.000	0.283	0.717
E02 Subclinical iodine-deficiency hypothyroidism	0.000	0.283	0.717
E10.7 With multiple complications	0.000	0.283	0.717
E05.5 Thyroid crisis or storm	0.000	0.283	0.717
E05.4 Thyrotoxicosis factitia	0.000	0.283	0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.000	0.283	0.717
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.000	0.283	0.717
E03.5 Myxoedema coma	0.000	0.283	0.717
E03.4 Atrophy of thyroid (acquired)	0.000	0.283	0.717
E03.3 Postinfectious hypothyroidism	0.000	0.283	0.717
E03.0 Congenital hypothyroidism with diffuse goitre	0.000	0.283	0.717
E12 Malnutrition-related diabetes mellitus	0.000	0.285	0.715
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.712	0.288	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.712	0.288	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.712	0.288	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.712	0.288	0.000
T43.9 Psychotropic drug, unspecified	0.710	0.289	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.710	0.289	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.710	0.289	0.000
E07 Other disorders of thyroid	0.000	0.292	0.708
T47.1 Other antacids and anti-gastric-secretion drugs	0.706	0.294	0.000
E64 Sequelae of malnutrition and other nutritional deficiencies	0.000	0.295	0.705
E63 Other nutritional deficiencies	0.000	0.295	0.705
E56 Other vitamin deficiencies	0.000	0.295	0.705
E51 Thiamine deficiency	0.000	0.295	0.705
E50 Vitamin A deficiency	0.000	0.295	0.705
E60 Dietary zinc deficiency	0.000	0.295	0.705
E59 Dietary selenium deficiency	0.000	0.295	0.705
E58 Dietary calcium deficiency	0.000	0.295	0.705
E54 Ascorbic acid deficiency	0.000	0.295	0.705
E52 Niacin deficiency [pellagra]	0.000	0.295	0.705
T36 Poisoning by systemic antibiotics	0.703	0.297	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.699	0.300	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.699	0.300	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.699	0.300	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.699	0.300	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.699	0.300	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.699	0.300	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.699	0.300	0.000
T44.0 Anticholinesterase agents	0.699	0.300	0.000
E53.9 Vitamin B deficiency, unspecified	0.000	0.305	0.695
E53.1 Pyridoxine deficiency	0.000	0.305	0.695
E53.0 Riboflavin deficiency	0.000	0.305	0.695
E61 Deficiency of other nutrient elements	0.000	0.308	0.692
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.691	0.309	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.691	0.309	0.000
T42.3 Barbiturates	0.691	0.309	0.000
T42.2 Succinimides and oxazolidinediones	0.691	0.309	0.000
T42.0 Hydantoin derivatives	0.691	0.309	0.000
K90 Intestinal malabsorption	0.000	0.309	0.691
T50.8 Diagnostic agents	0.689	0.311	0.000
T50.7 Analeptics and opioid receptor antagonists	0.689	0.311	0.000
T50.5 Appetite depressants	0.689	0.311	0.000
T50.4 Drugs affecting uric acid metabolism	0.689	0.311	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.689	0.311	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.689	0.311	0.000
T50.1 Loop [high-ceiling] diuretics	0.689	0.311	0.000
T50.0 Mineralocorticoids and their antagonists	0.689	0.311	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.682	0.318	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.000	0.319	0.681
E10.1 With ketoacidosis	0.000	0.320	0.680
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.678	0.322	0.000
E16 Other disorders of pancreatic internal secretion	0.000	0.344	0.656
E55.9 Vitamin D deficiency, unspecified	0.000	0.351	0.649
E13 Other specified diabetes mellitus	0.000	0.353	0.647
T39.4 Antirheumatics, not elsewhere classified	0.646	0.354	0.000
T39.2 Pyrazolone derivatives	0.646	0.354	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.644	0.356	0.000
T45.0 Antiallergic and antiemetic drugs	0.642	0.358	0.000
K90.9 Intestinal malabsorption, unspecified	0.000	0.361	0.639
E03.8 Other specified hypothyroidism	0.000	0.371	0.629
T42.1 Iminostilbenes	0.622	0.378	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.619	0.381	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.619	0.381	0.000
T47.7 Emetics	0.619	0.381	0.000
T47.6 Antidiarrhoeal drugs	0.619	0.381	0.000
T47.5 Digestants	0.619	0.381	0.000
T47.4 Other laxatives	0.619	0.381	0.000
T47.3 Saline and osmotic laxatives	0.619	0.381	0.000
T47.2 Stimulant laxatives	0.619	0.381	0.000
E03.1 Congenital hypothyroidism without goitre	0.000	0.384	0.616
E06.5 Other chronic thyroiditis	0.000	0.391	0.609
E06.4 Drug-induced thyroiditis	0.000	0.391	0.609
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.000	0.391	0.609
E06.1 Subacute thyroiditis	0.000	0.391	0.609
E06.0 Acute thyroiditis	0.000	0.391	0.609
T46.4 Angiotensin-converting-enzyme inhibitors	0.597	0.403	0.000
E07.9 Disorder of thyroid, unspecified	0.000	0.409	0.591
E15 Nondiabetic hypoglycaemic coma	0.000	0.427	0.573
E55.0 Rickets, active	0.000	0.434	0.565
E40-E46 Malnutrition	0.000	0.441	0.559
E04.8 Other specified non-toxic goitre	0.000	0.442	0.558
E06.9 Thyroiditis, unspecified	0.000	0.444	0.555
T46.1 Calcium-channel blockers	0.542	0.458	0.000
E16.2 Hypoglycaemia, unspecified	0.000	0.462	0.538
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.538	0.462	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.538	0.462	0.000
T46.7 Peripheral vasodilators	0.538	0.462	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.538	0.462	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.538	0.462	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.538	0.462	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.538	0.462	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.537	0.463	0.000
T45.8 Other primarily systemic and haematological agents	0.537	0.463	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.537	0.463	0.000
T45.6 Fibrinolysis-affecting drugs	0.537	0.463	0.000
T45.4 Iron and its compounds	0.537	0.463	0.000
T45.3 Enzymes, not elsewhere classified	0.537	0.463	0.000
T45.2 Vitamins, not elsewhere classified	0.537	0.463	0.000
E04.0 Non-toxic diffuse goitre	0.000	0.464	0.536
T38.1 Thyroid hormones and substitutes	0.534	0.466	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.000	0.467	0.533
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.522	0.478	0.000
T38.9 Other and unspecified hormone antagonists	0.514	0.486	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.514	0.486	0.000
T38.7 Androgens and anabolic congeners	0.514	0.486	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.514	0.486	0.000
T38.5 Other oestrogens and progestogens	0.514	0.486	0.000
T38.4 Oral contraceptives	0.514	0.486	0.000
T38.2 Antithyroid drugs	0.514	0.486	0.000
T38.0 Glucocorticoids and synthetic analogues	0.514	0.486	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.000	0.486	0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.000	0.486	0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.000	0.486	0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.000	0.486	0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.486	0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.000	0.486	0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.000	0.486	0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.000	0.486	0.514
E12.9 Without complications	0.000	0.487	0.512
E12.8 With unspecified complications	0.000	0.487	0.512
E12.7 With multiple complications	0.000	0.487	0.512
E12.6 With other specified complications	0.000	0.487	0.512
E12.5 With peripheral circulatory complications	0.000	0.487	0.512
E12.4 With neurological complications	0.000	0.487	0.512
E12.3 With ophthalmic complications	0.000	0.487	0.512
E12.2 With renal complications	0.000	0.487	0.512
E12.1 With ketoacidosis	0.000	0.487	0.512
E12.0 With coma	0.000	0.487	0.512
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.510	0.490	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.510	0.490	0.000
T37.5 Antiviral drugs	0.510	0.490	0.000
T37.4 Anthelminthics	0.510	0.490	0.000
T37.3 Other antiprotozoal drugs	0.510	0.490	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.510	0.490	0.000
T37.1 Antimycobacterial drugs	0.510	0.490	0.000
T37.0 Sulphonamides	0.510	0.490	0.000
T41.5 Therapeutic gases	0.510	0.490	0.000
T41.4 Anaesthetic, unspecified	0.510	0.490	0.000
T41.3 Local anaesthetics	0.510	0.490	0.000
T41.2 Other and unspecified general anaesthetics	0.510	0.490	0.000
T41.1 Intravenous anaesthetics	0.510	0.490	0.000
T41.0 Inhaled anaesthetics	0.510	0.490	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.510	0.490	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.510	0.490	0.000
T48.5 Anti-common-cold drugs	0.510	0.490	0.000
T48.4 Expectorants	0.510	0.490	0.000
T48.3 Antitussives	0.510	0.490	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.510	0.490	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.510	0.490	0.000
T48.0 Oxytocic drugs	0.510	0.490	0.000
T49.9 Topical agent, unspecified	0.510	0.490	0.000
T49.8 Other topical agents	0.510	0.490	0.000
T49.7 Dental drugs, topically applied	0.510	0.490	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.510	0.490	0.000
T49.5 Ophthalmological drugs and preparations	0.510	0.490	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.510	0.490	0.000
T49.3 Emollients, demulcents and protectants	0.510	0.490	0.000
T49.2 Local astringents and local detergents	0.510	0.490	0.000
T49.1 Antipruritics	0.510	0.490	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.510	0.490	0.000
E61.2 Magnesium deficiency	0.000	0.491	0.508
E07.1 Dyshormogenetic goitre	0.000	0.493	0.507
E07.0 Hypersecretion of calcitonin	0.000	0.493	0.507
E50.9 Vitamin A deficiency, unspecified	0.000	0.494	0.505
E50.8 Other manifestations of vitamin A deficiency	0.000	0.494	0.505
E50.7 Other ocular manifestations of vitamin A deficiency	0.000	0.494	0.505
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.000	0.494	0.505
E50.5 Vitamin A deficiency with night blindness	0.000	0.494	0.505
E50.4 Vitamin A deficiency with keratomalacia	0.000	0.494	0.505
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.000	0.494	0.505
E50.2 Vitamin A deficiency with corneal xerosis	0.000	0.494	0.505
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.000	0.494	0.505
E50.0 Vitamin A deficiency with conjunctival xerosis	0.000	0.494	0.505
E51.9 Thiamine deficiency, unspecified	0.000	0.494	0.505
E51.8 Other manifestations of thiamine deficiency	0.000	0.494	0.505
E51.2 Wernicke's encephalopathy	0.000	0.494	0.505
E51.1 Beriberi	0.000	0.494	0.505
E56.9 Vitamin deficiency, unspecified	0.000	0.494	0.505
E56.8 Deficiency of other vitamins	0.000	0.494	0.505
E56.1 Deficiency of vitamin K	0.000	0.494	0.505
E56.0 Deficiency of vitamin E	0.000	0.494	0.505
E63.9 Nutritional deficiency, unspecified	0.000	0.494	0.505
E63.8 Other specified nutritional deficiencies	0.000	0.494	0.505
E63.1 Imbalance of constituents of food intake	0.000	0.494	0.505
E63.0 Essential fatty acid [EFA] deficiency	0.000	0.494	0.505
E64.9 Sequelae of unspecified nutritional deficiency	0.000	0.494	0.505
E64.8 Sequelae of other nutritional deficiencies	0.000	0.494	0.505
E64.3 Sequelae of rickets	0.000	0.494	0.505
E64.2 Sequelae of vitamin C deficiency	0.000	0.494	0.505
E64.1 Sequelae of vitamin A deficiency	0.000	0.494	0.505
E64.0 Sequelae of protein-energy malnutrition	0.000	0.494	0.505
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.505	0.495	0.000
T36.9 Systemic antibiotic, unspecified	0.504	0.496	0.000
T36.8 Other systemic antibiotics	0.504	0.496	0.000
T36.7 Antifungal antibiotics, systemically used	0.504	0.496	0.000
T36.6 Rifamycins	0.504	0.496	0.000
T36.5 Aminoglycosides	0.504	0.496	0.000
T36.4 Tetracyclines	0.504	0.496	0.000
T36.3 Macrolides	0.504	0.496	0.000
T36.2 Chloramphenicol group	0.504	0.496	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.504	0.496	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.499	0.501	0.000
E61.9 Deficiency of nutrient element, unspecified	0.000	0.504	0.496
E61.8 Deficiency of other specified nutrient elements	0.000	0.504	0.496
E61.7 Deficiency of multiple nutrient elements	0.000	0.504	0.496
E61.6 Vanadium deficiency	0.000	0.504	0.496
E61.5 Molybdenum deficiency	0.000	0.504	0.496
E61.4 Chromium deficiency	0.000	0.504	0.496
E61.3 Manganese deficiency	0.000	0.504	0.496
E61.0 Copper deficiency	0.000	0.504	0.496
K90.3 Pancreatic steatorrhoea	0.000	0.505	0.495
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.505	0.495
K90.1 Tropical sprue	0.000	0.505	0.495
T36.0 Penicillins	0.495	0.505	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.494	0.506	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.000	0.511	0.489
E65-E68 Obesity and other hyperalimentation	0.000	0.518	0.482
E16.1 Other hypoglycaemia	0.000	0.522	0.478
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.524	0.476
E16.9 Disorder of pancreatic internal secretion, unspecified	0.000	0.529	0.471
E16.8 Other specified disorders of pancreatic internal secretion	0.000	0.529	0.471
E16.4 Abnormal secretion of gastrin	0.000	0.529	0.471
E16.3 Increased secretion of glucagon	0.000	0.529	0.471
E61.1 Iron deficiency	0.000	0.530	0.469
E13.8 With unspecified complications	0.000	0.536	0.464
E13.7 With multiple complications	0.000	0.536	0.464
E13.6 With other specified complications	0.000	0.536	0.464
E13.5 With peripheral circulatory complications	0.000	0.536	0.464
E13.4 With neurological complications	0.000	0.536	0.464
E13.3 With ophthalmic complications	0.000	0.536	0.464
E13.2 With renal complications	0.000	0.536	0.464
E13.1 With ketoacidosis	0.000	0.536	0.464
E13.0 With coma	0.000	0.536	0.464
K90.8 Other intestinal malabsorption	0.000	0.536	0.464
T45.5 Anticoagulants	0.463	0.537	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.406	0.594	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.000	0.599	0.401
E45 Retarded development following protein-energy malnutrition	0.000	0.599	0.401
E43 Unspecified severe protein-energy malnutrition	0.000	0.599	0.401
E42 Marasmic kwashiorkor	0.000	0.599	0.401
E41 Nutritional marasmus	0.000	0.599	0.401
E40 Kwashiorkor	0.000	0.599	0.401
E04.1 Non-toxic single thyroid nodule	0.000	0.601	0.399
M07.3 Other psoriatic arthropathies	0.398	0.602	0.000
E13.9 Without complications	0.000	0.603	0.397
E14 Unspecified diabetes mellitus	0.000	0.604	0.396
M07.39 Other psoriatic arthropathies (Site unspecified)	0.389	0.611	0.000
E07.8 Other specified disorders of thyroid	0.001	0.652	0.347
E67 Other hyperalimentation	0.000	0.654	0.345
E68 Sequelae of hyperalimentation	0.000	0.654	0.345
M07.36 Other psoriatic arthropathies (Lower leg)	0.334	0.666	0.000
M07.34 Other psoriatic arthropathies (Hand)	0.322	0.678	0.000
E14.3 With ophthalmic complications	0.000	0.691	0.309
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.303	0.697	0.000
E44.1 Mild protein-energy malnutrition	0.000	0.712	0.287
E44.0 Moderate protein-energy malnutrition	0.000	0.712	0.287
M07.38 Other psoriatic arthropathies (Other)	0.285	0.714	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.285	0.714	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.285	0.714	0.000
M07.32 Other psoriatic arthropathies (Upper arm)	0.285	0.714	0.000
M07.31 Other psoriatic arthropathies (Shoulder region)	0.285	0.714	0.000
E14.8 With unspecified complications	0.000	0.716	0.284
E14.7 With multiple complications	0.000	0.716	0.284
E14.6 With other specified complications	0.000	0.716	0.284
E14.2 Withrenal complications	0.000	0.716	0.284
E14.0 With coma	0.000	0.716	0.284
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.283	0.716	0.001
E14.4 With neurological complications	0.000	0.722	0.278
E20-E35 Disorders of other endocrine glands	0.000	0.726	0.274
E65 Localised adiposity	0.000	0.734	0.266
E04.2 Non-toxic multinodular goitre	0.000	0.745	0.255
E67.8 Other specified hyperalimentation	0.000	0.752	0.248
E67.3 Hypervitaminosis D	0.000	0.752	0.248
E67.2 Megavitamin-B6 syndrome	0.000	0.752	0.248
E67.1 Hypercarotenaemia	0.000	0.752	0.248
E67.0 Hypervitaminosis A	0.000	0.752	0.248
E66 Obesity	0.000	0.752	0.248
E46 Unspecified protein-energy malnutrition	0.001	0.755	0.245
E14.5 With peripheral circulatory complications	0.000	0.755	0.244
E27 Other disorders of adrenal gland	0.000	0.756	0.244
E14.1 With ketoacidosis	0.000	0.760	0.240
E27.1 Primary adrenocortical insufficiency	0.000	0.768	0.232
L40-L45 Papulosquamous disorders	0.216	0.783	0.000
E66.8 Other obesity	0.000	0.791	0.209
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.203	0.796	0.001
T40.8 Lysergide [LSD]	0.203	0.796	0.001
T40.7 Cannabis (derivatives)	0.203	0.796	0.001
T40.5 Cocaine	0.203	0.796	0.001
T40.3 Methadone	0.203	0.796	0.001
T40.1 Heroin	0.203	0.796	0.001
T40.0 Opium	0.203	0.796	0.001
E34 Other endocrine disorders	0.000	0.797	0.203
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.803	0.196
E32 Diseases of thymus	0.000	0.803	0.196
E31 Polyglandular dysfunction	0.000	0.803	0.196
E30 Disorders of puberty, not elsewhere classified	0.000	0.803	0.196
E25 Adrenogenital disorders	0.000	0.803	0.196
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.196	0.804	0.001
E27.8 Other specified disorders of adrenal gland	0.000	0.810	0.190
E24 Cushing's syndrome	0.000	0.812	0.188
E29 Testicular dysfunction	0.000	0.815	0.185
T40.6 Other and unspecified narcotics	0.184	0.815	0.001
E28 Ovarian dysfunction	0.000	0.819	0.181
E27.2 Addisonian crisis	0.000	0.820	0.180
E66.1 Drug-induced obesity	0.000	0.822	0.178
E27.5 Adrenomedullary hyperfunction	0.000	0.825	0.175
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.825	0.175
E27.0 Other adrenocortical overactivity	0.000	0.825	0.175
M07 Psoriatic and enteropathic arthropathies	0.174	0.826	0.000
E20 Hypoparathyroidism	0.000	0.827	0.172
E66.2 Extreme obesity with alveolar hypoventilation	0.000	0.828	0.172
E70-E90 Metabolic disorders	0.000	0.828	0.172
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.171	0.829	0.000
E22 Hyperfunction of pituitary gland	0.000	0.832	0.168
E66.0 Obesity due to excess calories	0.000	0.836	0.164
E34.8 Other specified endocrine disorders	0.000	0.837	0.163
T20-T25 Burns and corrosions of external body surface, specified by site	0.162	0.838	0.000
S80-S89 Injuries to the knee and lower leg	0.162	0.838	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.000	0.838	0.161
S82 Fracture of lower leg, including ankle	0.159	0.841	0.000
E89.0 Postprocedural hypothyroidism	0.000	0.842	0.158
E26 Hyperaldosteronism	0.000	0.843	0.156
L44 Other papulosquamous disorders	0.155	0.844	0.000
L41 Parapsoriasis	0.155	0.844	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.155	0.844	0.000
E28.3 Primary ovarian failure	0.000	0.846	0.154
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.846	0.154
S82.1 Fracture of upper end of tibia	0.150	0.850	0.000
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.150	0.850	0.000
E34.5 Androgen resistance syndrome	0.000	0.854	0.145
E34.4 Constitutional tall stature	0.000	0.854	0.145
E34.3 Short stature, not elsewhere classified	0.000	0.854	0.145
E34.2 Ectopic hormone secretion, not elsewhere classified	0.000	0.854	0.145
E34.1 Other hypersecretion of intestinal hormones	0.000	0.854	0.145
S82.10 Fracture of upper end of tibia (closed)	0.145	0.855	0.000
S82.5 Fracture of medial malleolus	0.144	0.855	0.000
E73 Lactose intolerance	0.000	0.856	0.144
S82.6 Fracture of lateral malleolus	0.144	0.856	0.000
T40.4 Other synthetic narcotics	0.141	0.858	0.001
E25.9 Adrenogenital disorder, unspecified	0.000	0.859	0.141
E25.8 Other adrenogenital disorders	0.000	0.859	0.141
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.000	0.859	0.141
E30.9 Disorder of puberty, unspecified	0.000	0.859	0.141
E30.8 Other disorders of puberty	0.000	0.859	0.141
E30.1 Precocious puberty	0.000	0.859	0.141
E30.0 Delayed puberty	0.000	0.859	0.141
E31.9 Polyglandular dysfunction, unspecified	0.000	0.859	0.141
E31.8 Other polyglandular dysfunction	0.000	0.859	0.141
E31.1 Polyglandular hyperfunction	0.000	0.859	0.141
E31.0 Autoimmune polyglandular failure	0.000	0.859	0.141
E32.9 Disease of thymus, unspecified	0.000	0.859	0.141
E32.8 Other diseases of thymus	0.000	0.859	0.141
E32.1 Abscess of thymus	0.000	0.859	0.141
E32.0 Persistent hyperplasia of thymus	0.000	0.859	0.141
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.000	0.859	0.141
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.000	0.859	0.141
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.000	0.859	0.141
E34.9 Endocrine disorder, unspecified	0.000	0.859	0.140
E24.9 Cushing's syndrome, unspecified	0.000	0.860	0.140
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.139	0.861	0.000
E74 Other disorders of carbohydrate metabolism	0.000	0.861	0.139
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.861	0.139
T25 Burn and corrosion of ankle and foot	0.137	0.863	0.000
E22.1 Hyperprolactinaemia	0.000	0.864	0.136
E34.0 Carcinoid syndrome	0.000	0.864	0.136
S10-S19 Injuries to the neck	0.136	0.864	0.000
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.136	0.864	0.000
S30 Superficial injury of abdomen, lower back and pelvis	0.135	0.864	0.000
E24.8 Other Cushing's syndrome	0.000	0.865	0.135
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.000	0.865	0.135
E24.3 Ectopic ACTH syndrome	0.000	0.865	0.135
E24.1 Nelson's syndrome	0.000	0.865	0.135
E24.0 Pituitary-dependent Cushing's disease	0.000	0.865	0.135
S82.50 Fracture of medial malleolus (closed)	0.134	0.866	0.000
T15-T19 Effects of foreign body entering through natural orifice	0.133	0.866	0.000
S82.60 Fracture of lateral malleolus (closed)	0.133	0.867	0.000
L42 Pityriasis rosea	0.133	0.867	0.000
E29.9 Testicular dysfunction, unspecified	0.000	0.867	0.133
E29.8 Other testicular dysfunction	0.000	0.867	0.133
E29.0 Testicular hyperfunction	0.000	0.867	0.133
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.133	0.867	0.000
T66-T78 Other and unspecified effects of external causes	0.131	0.869	0.000
S86 Injury of muscle and tendon at lower leg level	0.131	0.869	0.000
S90-S99 Injuries to the ankle and foot	0.131	0.869	0.000
E28.9 Ovarian dysfunction, unspecified	0.000	0.870	0.130
E28.8 Other ovarian dysfunction	0.000	0.870	0.130
E28.1 Androgen excess	0.000	0.870	0.130
E28.0 Oestrogen excess	0.000	0.870	0.130
S82.4 Fracture of fibula alone	0.129	0.871	0.000
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.128	0.872	0.000
T21 Burn and corrosion of trunk	0.127	0.873	0.000
T00-T07 Injuries involving multiple body regions	0.127	0.873	0.000
S82.0 Fracture of patella	0.126	0.873	0.000
E89.2 Postprocedural hypoparathyroidism	0.000	0.873	0.126
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.125	0.874	0.000
M07.6 Other enteropathic arthropathies	0.125	0.875	0.000
M07.5 Arthropathy in ulcerative colitis	0.125	0.875	0.000
M07.4 Arthropathy in Crohn's disease [regional enteritis]	0.125	0.875	0.000
M07.2 Psoriatic spondylitis	0.125	0.875	0.000
M07.1 Arthritis mutilans	0.125	0.875	0.000
M07.0 Distal interphalangeal psoriatic arthropathy	0.125	0.875	0.000
E73.9 Lactose intolerance, unspecified	0.000	0.876	0.124
E20.8 Other hypoparathyroidism	0.000	0.876	0.124
E20.1 Pseudohypoparathyroidism	0.000	0.876	0.124
E20.0 Idiopathic hypoparathyroidism	0.000	0.876	0.124
T20 Burn and corrosion of head and neck	0.124	0.876	0.000
S91 Open wound of ankle and foot	0.123	0.877	0.000
E84 Cystic fibrosis	0.000	0.877	0.123
E79 Disorders of purine and pyrimidine metabolism	0.000	0.877	0.123
E77 Disorders of glycoprotein metabolism	0.000	0.877	0.123
E76 Disorders of glycosaminoglycan metabolism	0.000	0.877	0.123
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.000	0.877	0.123
E72 Other disorders of amino-acid metabolism	0.000	0.877	0.123
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.000	0.877	0.123
E70 Disorders of aromatic amino-acid metabolism	0.000	0.877	0.123
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.000	0.877	0.123
T33-T35 Frostbite	0.123	0.877	0.000
T26-T28 Burns and corrosions confined to eye and internal organs	0.123	0.877	0.000
E29.1 Testicular hypofunction	0.000	0.878	0.121
E22.9 Hyperfunction of pituitary gland, unspecified	0.000	0.879	0.121
E22.8 Other hyperfunction of pituitary gland	0.000	0.879	0.121
E24.2 Drug-induced Cushing's syndrome	0.000	0.880	0.120
E14.9 Without complications	0.000	0.881	0.119
S36 Injury of intra-abdominal organs	0.119	0.881	0.000
S30.2 Contusion of external genital organs	0.119	0.881	0.000
E27.9 Disorder of adrenal gland, unspecified	0.000	0.882	0.117
T79-T79 Certain early complications of trauma	0.117	0.883	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations